Back to TCRX
GEODE CAPITAL MANAGEMENT, LLC → TCRX
GEODE CAPITAL MANAGEMENT, LLC TCRX Position History
TScan Therapeutics, Inc. • Healthcare
Quarters held
10
Latest value
$36K
Q3 2026
Peak value
$853K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $853K |
| Q3 2025 | $180K |
| Q4 2025 | $458K |
| Q4 2025 | $104K |
| Q1 2026 | $515K |
| Q1 2026 | $109K |
| Q2 2026 | $467K |
| Q2 2026 | $107K |
| Q3 2026 | $154K |
| Q3 2026 | $36K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $36K | 115.6K | — | — |
| Q3 2026 | $154K | 488.7K | — | — |
| Q2 2026 | $107K | 109.0K | — | — |
| Q2 2026 | $467K | 475.8K | — | — |
| Q1 2026 | $109K | 107.5K | — | — |
| Q1 2026 | $515K | 509.5K | — | — |
| Q4 2025 | $104K | 104.0K | — | — |
| Q4 2025 | $458K | 458.2K | — | — |
| Q3 2025 | $180K | 99.0K | — | — |
| Q3 2025 | $853K | 468.6K | — | — |
Other funds holding TCRX
$630M
$630M
$617.5M
$198.1M
$10.9M